| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PD.1970100406 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpd.1970100406 |
| https://onlinelibrary.wiley.com/doi/full/10.1002/pd.1970100406 | ||
| P698 | PubMed publication ID | 1694994 |
| P2093 | author name string | D. J. Brock | |
| L. Barron | |||
| W. A. Liston | |||
| S. G. Hillier | |||
| S. Holloway | |||
| M. Seppala | |||
| P2860 | cites work | Maternal serum screening for Down's syndrome in early pregnancy | Q35703368 |
| Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities | Q44259917 | ||
| First-trimester maternal serum alpha-fetoprotein screening for chromosome defects | Q45030565 | ||
| Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses. | Q46029438 | ||
| A Simple Method for Ranking the Affinities of Monoclonal Antibodies | Q59662168 | ||
| Fetal chromosomal aneuploidies and maternal serum alpha-fetoprotein levels in first trimester | Q68966627 | ||
| Measurement of placental alkaline phosphatase in maternal plasma as an indicator of subsequent low birthweight outcome | Q69018189 | ||
| Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome | Q69029876 | ||
| Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening | Q69059112 | ||
| Maternal serum specific beta 1-glycoprotein in pregnancies associated with Down's syndrome | Q69372764 | ||
| First-trimester biochemical screening for Down syndrome | Q69924894 | ||
| Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome | Q70056433 | ||
| Maternal levels of pregnancy-specific beta 1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndrome | Q70060870 | ||
| Pregnancy-specific beta-1 glycoprotein in ectopic pregnancy | Q72073056 | ||
| An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities | Q72729435 | ||
| Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome | Q72730932 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Down syndrome | Q47715 |
| P304 | page(s) | 245-251 | |
| P577 | publication date | 1990-04-01 | |
| P1433 | published in | Prenatal Diagnosis | Q15760059 |
| P1476 | title | First-trimester maternal serum biochemical indicators in Down syndrome | |
| P478 | volume | 10 |
| Q71598362 | A sensitive enzyme immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies |
| Q67708004 | Alpha-fetoprotein in fetal serum, amniotic fluid, and maternal serum |
| Q73405981 | Evaluation of two markers of cell maturation and proliferation in cultured amniotic cells of trisomic 18 fetuses at the 15th week of gestation |
| Q36308492 | First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening. |
| Q33768998 | First trimester screening for aneuploidy: serum biochemical markers |
| Q24187589 | First trimester serum tests for Down's syndrome screening |
| Q36308489 | First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening |
| Q45291831 | First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. |
| Q46788795 | First-trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone |
| Q34333074 | First-trimester biochemical screening for Down syndrome |
| Q71620967 | First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG |
| Q67706859 | First-trimester maternal serum alphafetoprotein and chorionic gonadotropin in aneuploid pregnancies |
| Q44687871 | First-trimester maternal serum unconjugated oestriol and alpha-fetoprotein in fetal Down's syndrome |
| Q72099388 | First‐trimester free beta (hCG) screening for Down syndrome |
| Q72080653 | Low maternal serum levels of pregnancy associated plasma protein A (PAPP‐A) in the first trimester in association with abnormal fetal karyotype |
| Q35977631 | Production of placental alkaline phosphatase (PLAP) and PLAP-like material by epithelial germ cell and non-germ cell tumours in vitro |
| Q73134756 | Schwangerschaftsprotein 1 (SP1) as a maternal serum marker for Down syndrome in the first and second trimesters |
| Q67700323 | Screening for fetal Down's syndrome with maternal serum markers—an experience in italy |
| Q22252964 | Second trimester serum tests for Down's Syndrome screening |
| Q72099390 | Serum PAPP‐A levels are depressed in women with fetal Down syndrome in early pregnancy |
| Q67540892 | The effect of gestational age on maternal serum alpha-fetoprotein levels in pregnancies with Down syndrome |
| Q72087901 | The use of free β‐hCG in antenatal screening for Down's syndrome |
| Q24186912 | Urine tests for Down's syndrome screening |
Search more.